Vaccines for Mycoplasma bovis and methods of use

Details Vaccines for Mycoplasma bovis and methods of use Vaccines for Mycoplasma bovis and methods of use

2003-12-02

2008-09-30

Minnifield, N. M. (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S184100, C424S185100, C435S007100, C435S007200, C435S041000, C530S300000, C530S324000

Reexamination Certificate

active

07429389

ABSTRACT:
The invention of novel, effective vaccines againstMycoplasma bovisfor use in cattle is described. These vaccines demonstrate no undesirable side effects and protect againstM. bovisrelated disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections. The novel vaccines also lessen the effectM. bovisinfections on milk production, weight gain and animal health. Methods of diagnosing characterizing and treatingM. bovisinfections as specific biotypes are also disclosed. Vaccine compositions made in accordance with the invention may be either of the attenuated or inactivated variety. Vaccines may also include antigens from other pathogens so as to provide a protective immunogenic response to diseases other than those caused byM. bovis.

REFERENCES:
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4517304 (1985-05-01), Stott et al.
patent: 4981684 (1991-01-01), MacKenzie et al.
patent: 5178860 (1993-01-01), MacKenzie et al.
patent: 5338543 (1994-08-01), Fitzgerald et al.
patent: 5565205 (1996-10-01), Petersen et al.
patent: 5585098 (1996-12-01), Coleman
patent: 5665363 (1997-09-01), Hansen et al.
patent: 5968525 (1999-10-01), Fitzgerald et al.
patent: 6548069 (2003-04-01), Hymas et al.
patent: 29921392 (1998-12-01), None
Boothby et al (Cornell Vet. 1986, Apr., 76(2), 188-197).
Koshi et al, (Journal of Biological Standardization 1976, 4, 151-154).
Poumarat et al (Veterinary Microbiology, vol. 40, 1994.
Rawadi (G.A., Characterization of Mycoplasmas by RAPD Fingerprinting, Methods in Molecular Biology, 104:179-187).
Straub (Comp Immunol Microbiol Infect Dis., 1991; 14(2):175-86).
Gordis (Epidemiology, third Edition, 2004) pp. 33-37.
Artiushin et al., Arbitrarily Primed PCR Analysis of Mycoplasma hyopneumoniae Field Isolates Demonstrates Genetic Heterogeneity. Int Journal of Systematic Bacteriology, 46:324-328 (1996).

Affiliated with

Also associated with

Rating

Vaccines for Mycoplasma bovis and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccines for Mycoplasma bovis and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines for Mycoplasma bovis and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3985276